Loading…
Lobbying Spend
—
Filings
28
Firms Hired
1
Active Period
2020–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
To explore the implications from mandatory dietary supplement product listing provisions (as previously included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry in the dietary supplement channel; to explore health savings accounts / flexible spending accounts in relation to dietary supplement products.
Client expense: — · Firm income: $10,000
Matched citations: S.4348
To explore the implications from mandatory dietary supplement product listing provisions (as previously included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry in the dietary supplement channel; to explore health savings accounts / flexible spending accounts in relation to dietary supplement products.
Client expense: — · Firm income: $10,000
Matched citations: S.4348
To explore the implications from mandatory dietary supplement product listing provisions (as previously included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry in the dietary supplement channel; to explore health savings accounts / flexible spending accounts in relation to dietary supplement products.
Client expense: — · Firm income: $10,000
Matched citations: S.4348
To explore the implications from mandatory dietary supplement product listing provisions (as previously included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry in the dietary supplement channel.
Client expense: — · Firm income: $10,000
Matched citations: S.4348
To clarify the regulatory uncertainty of the hemp-derived cannabidiol ingredient; to explore the implications from mandatory dietary supplement product listing provisions (as previoulsy included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry.
Client expense: — · Firm income: $10,000
Matched citations: S.4348
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient; and to explore the implications from the mandatory dietary supplement product listing provisions as included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348).
Client expense: — · Firm income: —
Matched citations: S.4348
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient; and to explore the implications from the mandatory dietary supplement product listing provisions as included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348).
Client expense: — · Firm income: —
Matched citations: S.4348
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient; and to explore the implications from the mandatory dietary supplement product listing provisions as included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348).
Client expense: — · Firm income: —
Matched citations: S.4348
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · fourth_quarter · Firm: MS. TAMI WAHL
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: —
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · fourth_quarter · Firm: MS. TAMI WAHL
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: —
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · third_quarter · Firm: MS. TAMI WAHL
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: $20,000
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · third_quarter · Firm: MS. TAMI WAHL
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: $20,000
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · second_quarter · Firm: MS. TAMI WAHL
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: $10,000
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · second_quarter · Firm: MS. TAMI WAHL
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: $10,000
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · first_quarter · Firm: MS. TAMI WAHL
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: $10,000
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · first_quarter · Firm: MS. TAMI WAHL
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: $10,000
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · first_quarter · Firm: MS. TAMI WAHL
To advance HR5587, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: —
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · first_quarter · Firm: MS. TAMI WAHL
To advance HR5587, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: —
Matched citations: HR5587
Source: Senate LDA